Homestreet HMST 深 滬
已收盤 08-22 16:00:00 美东时间
13.90
+0.140
+1.02%
華盛通- 最 高14.58
- 今 開13.85
- 成交量 13.56万股
- 最 低 13.76
- 昨 收 13.76
- 總市值 2.63亿
- 52周最高 16.10
- 市盈率 靜 --
- 換手率 0.72%
- 52周最低 8.41
- 委 比 -5.77%
- 總股本 1892.08万
- 歷史最高 55.35
- 量 比 1.77
- 振 幅 5.96%
- 歷史最低 4.10
- 每 手 1
- 風險率 3.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HomeStreet and Mechanics Bank Merger Receives Approval
HomeStreet ( ($HMST) ) has shared an announcement. On August 19, 2025, HomeStre...
08-19 20:59
十大虚假空投危险信号及避坑指南
（来源：吴说） 作者：Dilip Kumar Patairya 编译：Tim，PANews 原文链接：https://mp.weixin.qq.com/s/...
08-17 22:18
HomeStreet SEC Approval Advances Mechanics Bank Merger
HomeStreet ( ($HMST) ) has provided an announcement. On March 28, 2025, HomeStr...
08-08 02:47
HomeStreet Q2 Adj. EPS $(0.16) Misses $0.04 Estimate, Sales $48.97M Beat $48.20M Estimate
HomeStreet (NASDAQ:HMST) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $0.04 by 532.43 percent. This is a 30.43 percent increase over losses of $(0.23) per share from the
07-29 04:11
HomeStreet Elects Board at Annual Shareholder Meeting
HomeStreet ( ($HMST) ) just unveiled an update. On May 29, 2025, HomeStreet Inc...
06-03 02:27
美股大行评级 | 潜在涨幅105.34%！Amylyx Pharmaceuticals获Leerink Partners升目标价至10美元，上调至"跑赢大市"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
05-08 08:45
Keefe, Bruyette & Woods Maintains Market Perform on HomeStreet, Raises Price Target to $13.5
Keefe, Bruyette & Woods analyst Wood Lay maintains HomeStreet (NASDAQ:HMST) with a Market Perform and raises the price target from $12 to $13.5.
05-07 23:54
HomeStreet Announces Merger with Mechanics Bank
HomeStreet ( ($HMST) ) just unveiled an announcement. On March 28, 2025, HomeSt...
04-04 03:57
美股大行评级 | 潜在涨幅4159%！HC Wainwright & Co.上调BiomX目标价至21美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114111385008877568.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BiomX(PHGE)"买入"评级，目标价从2美元升至21美元</p> <p>• HC Wainwright & Co.：维持Unicycive Therapeu
04-02 09:42
